Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL7425174

CONN=Cc1cccc(CN2CC[C@@H](CN)C2=O)c1.O=C(O)C(F)(F)F

nearest known ligand 0.36

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
HRH2 P25021 3/20 0.36
OPRK1 P41145 1/20 0.34
ACHE P22303 2/20 0.34
GPR6 P46095 3/20 0.34
ALDH1A1 P00352 3/20 0.33
HDAC3 O15379 2/20 0.33
HDAC2 Q92769 2/20 0.33
HDAC8 Q9BY41 2/20 0.33
NCOR2 Q9Y618 2/20 0.33
CTSL P07711 1/20 0.33
F2 P00734 1/20 0.33
F10 P00742 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL7424588 0.87 F10 (0.37) OPRK1ACHEGPR6HDAC8F2
Trifluoroacetic Acid SCHEMBL7423282 0.86 HRH2 (0.35) HRH2GPR6CTSLF2F10
Trifluoroacetic Acid SCHEMBL7418499 0.86 KCNH2 (0.35) HRH2GPR6HDAC3HDAC2HDAC8
SCHEMBL7413862 0.77 KCNH2 (0.37) F2F10
Trifluoroacetic Acid SCHEMBL7419282 0.77 HDAC8 (0.41) HDAC3HDAC2HDAC8NCOR2F10
Trifluoroacetic Acid SCHEMBL2329902 0.75 F10 (0.35) HRH2GPR6HDAC8F2F10
Trifluoroacetic Acid SCHEMBL8834439 0.75 F10 (0.35) HRH2GPR6HDAC8F2F10
Trifluoroacetic Acid SCHEMBL7421271 0.75 F10 (0.35) HRH2GPR6HDAC8F2F10
Trifluoroacetic Acid SCHEMBL7423939 0.72 OPRD1 (0.36) HRH2F2F10
Trifluoroacetic Acid SCHEMBL7421816 0.71 NPY1R (0.38) HRH2ALDH1A1F2F10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0853618-A4 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE POULENC RORER PHARMA (US) 2000-03-15 EP claimed
EP-0853618-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-07-22 EP claimed
WO-1996040679-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-12-19 WO claimed
EP-0853618-A4 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE POULENC RORER PHARMA (US) 2000-03-15 EP disclosed
EP-0853618-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N- (AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHONE-POULENC RORER PHARMACEUTICALS, INC. (US) 1998-07-22 EP disclosed
WO-1996040679-A1 SUBSTITUTED (SULFINIC ACID, SULFONIC ACID, SULFONYLAMINO OR SULFINYLAMINO) N-[(AMINOIMINOMETHYL)PHENYLALKYL]-AZAHETEROCYCLYLAMIDE COMPOUNDS RHÔNE-POULENC RORER PHARMACEUTICALS INC. (US) 1996-12-19 WO disclosed